Drawing for SINUS DYNAMICS PHARMACY

USPTO serial 85560783

SINUS DYNAMICS PHARMACY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
MICHELI, ANGELA M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SINUS DYNAMICS PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christine M. Baker

CHRISTINE M. BAKER MINTZ LEVIN COHN FERRIS GLOVSKY & POPEO, PC666 3RD AVE FL 24NEW YORK, NY 10017-4040UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antibacterial pharmaceuticals; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; homeopathic pharmaceuticals for use in the treatment of sinusitis; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhalers filled with anti-infectives; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of sinusitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases and cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceuticals, namely, anti-infectives; synthetic peptides for pharmaceutical purposes; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industryACTIVE
035Retail pharmacy services; retail store pharmacy services in the field of prescription drugs; mail order of pharmaceuticals; specialty pharmaceutical distributorship services; pharmaceutical cost management for the health care benefit plans of others; retail and online retail store pharmacy services in the field of prescription drugs, healthcare and beauty products; retail store and mail order pharmacy services in the field of prescription drugs and patient, prescription and drug therapy information; retail store services, namely, pharmacy, retail drug store and general merchandise store services; mail order of pharmaceuticals, specialty pharmaceutical distributorship services; pharmaceutical cost management for health care benefit plans for others; administering pharmacy reimbursement programs and services; promoting public awareness of the value of using generic drugs; processing mail order prescription drug refill orders in retail and central fill pharmacies; processing online and telephone prescription orders in retail and central fill pharmaciesACTIVE
044Pharmaceutical consultation; consulting with patients regarding the administration of medicine and the use of medical devices; providing a physician resource for clinical questions about medications; providing a website featuring information about, and through which, customers can obtain information about general health topics, pharmaceutical therapies and disease state management; providing medical information regarding patients, prescription drugs and drug therapy; providing health care information and consulting services in the field of disease management and medical condition management; providing medical information regarding patients, prescription drugs and drug therapy; developing and managing comprehensive programs involving drug therapy and physican support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; therapeutic pharmaceutical services, namely, the development and management of comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; drug utilization review dispensing services, namely, identifying possible drug to drug interactions prior to dispensing new prescribed medications and possible drug allergic reactions given a patient's drug allergy historyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 31, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 31, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 19, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Feb 18, 2015EX3GSOU EXTENSION 3 GRANTED
Jan 30, 2015EXT3SOU EXTENSION 3 FILED
Jan 30, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 5, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Aug 4, 2014EX2GSOU EXTENSION 2 GRANTED
Jul 25, 2014EXT2SOU EXTENSION 2 FILED
Jul 25, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Feb 27, 2014EX1GSOU EXTENSION 1 GRANTED
Feb 24, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 24, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 30, 2014EXT1SOU EXTENSION 1 FILED
Jan 30, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2013NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2013NPUBNOTICE OF PUBLICATION
Apr 26, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 26, 2013ALIEASSIGNED TO LIE
Apr 15, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2012DOCKASSIGNED TO EXAMINER
Mar 12, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Frequently asked questions

Related guidance